Abeona Therapeutics (ABEO) Payables (2016 - 2025)
Historic Payables for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to $5.9 million.
- Abeona Therapeutics' Payables rose 11251.34% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 11251.34%. This contributed to the annual value of $3.4 million for FY2024, which is 8519.91% up from last year.
- Latest data reveals that Abeona Therapeutics reported Payables of $5.9 million as of Q3 2025, which was up 11251.34% from $7.3 million recorded in Q2 2025.
- Over the past 5 years, Abeona Therapeutics' Payables peaked at $7.3 million during Q2 2025, and registered a low of $1.5 million during Q2 2021.
- Over the past 5 years, Abeona Therapeutics' median Payables value was $2.8 million (recorded in 2024), while the average stood at $3.1 million.
- Its Payables has fluctuated over the past 5 years, first tumbled by 5812.72% in 2022, then soared by 13675.38% in 2025.
- Over the past 5 years, Abeona Therapeutics' Payables (Quarter) stood at $4.3 million in 2021, then tumbled by 58.13% to $1.8 million in 2022, then grew by 2.6% to $1.9 million in 2023, then soared by 85.2% to $3.4 million in 2024, then soared by 72.25% to $5.9 million in 2025.
- Its Payables stands at $5.9 million for Q3 2025, versus $7.3 million for Q2 2025 and $5.0 million for Q1 2025.